newsfilter
← Latest News
Business Wire·

Arcellx Provides First Quarter 2025 Financial Results and Business Highlights

-- iMMagine-1 data accepted for Oral Presentation at EHA -- -- iMMagine-3 study updated to include MRD negativity as a dual primary endpoint -- -- Added two new Board members with commercial and operational expertise